Michael Petry
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $223.85 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $76.82 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $36.91 | 3 | $0 (2020) |
| Lilly USA, LLC | $30.37 | 2 | $0 (2020) |
| Amgen Inc. | $28.02 | 2 | $0 (2019) |
| Novo Nordisk Inc | $15.16 | 1 | $0 (2020) |
| Allergan, Inc. | $14.50 | 1 | $0 (2020) |
| PFIZER INC. | $11.27 | 1 | $0 (2019) |
| Genentech USA, Inc. | $10.80 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $68.02 | 5 | Novo Nordisk Inc ($15.16) |
| 2019 | $90.01 | 7 | Amgen Inc. ($28.02) |
| 2017 | $65.82 | 3 | GlaxoSmithKline, LLC. ($65.82) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/04/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.16 | General |
| 01/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 12/06/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/22/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 11/19/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Virology & Specialty Care | ||||||
| 11/13/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Bone Health | ||||||
| 10/30/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/25/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/11/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Neuroscience | ||||||
| 11/21/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: RESPIRATORY | ||||||
| 08/08/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 677 | 873 | $185,382 | $52,927 |
| 2022 | 15 | 635 | 832 | $171,780 | $50,007 |
| 2021 | 14 | 574 | 757 | $155,633 | $46,194 |
| 2020 | 11 | 346 | 458 | $83,639 | $21,465 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 143 | 239 | $73,033 | $18,454 | 25.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 101 | 101 | $33,327 | $12,269 | 36.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 22 | 22 | $23,650 | $6,166 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 92 | $19,075 | $4,885 | 25.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 38 | 38 | $10,070 | $2,733 | 27.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,700 | $1,875 | 32.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $5,368 | $1,716 | 32.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 201 | $3,328 | $1,688 | 50.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $3,420 | $1,087 | 31.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 17 | $2,074 | $630.60 | 30.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $1,980 | $629.20 | 31.8% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 15 | $1,273 | $330.21 | 25.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 27 | $1,971 | $238.00 | 12.1% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 14 | 14 | $630.00 | $172.90 | 27.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 22 | 24 | $483.00 | $52.80 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 251 | $76,555 | $19,944 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 99 | 99 | $32,571 | $12,124 | 37.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $12,155 | $3,615 | 29.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 44 | 44 | $10,105 | $3,012 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 50 | $10,350 | $2,637 | 25.5% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2022 | 14 | 15 | $6,420 | $2,110 | 32.9% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 11 | 13 | $6,006 | $1,981 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $7,472 | $1,362 | 18.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 47 | 47 | $4,070 | $1,241 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 131 | 202 | $1,818 | $597.84 | 32.9% |
About Michael Petry
Michael Petry is a Student in an Organized Health Care Education/Training Program healthcare provider based in Crestwood, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2016. The National Provider Identifier (NPI) number assigned to this provider is 1003270422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Petry has received a total of $223.85 in payments from pharmaceutical and medical device companies, with $68.02 received in 2020. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($223.85).
As a Medicare-enrolled provider, Petry has provided services to 2,232 Medicare beneficiaries, totaling 2,920 services with total Medicare billing of $170,593. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Crestwood, KY
- Active Since 04/12/2016
- Last Updated 12/08/2021
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1003270422
Products in Payments
- NUCALA (Biological) $65.82
- FARXIGA (Drug) $36.91
- BASAGLAR (Drug) $30.37
- EVENITY (Biological) $15.08
- UBRELVY (Drug) $14.50
- Aimovig (Biological) $12.94
- CHANTIX (Drug) $11.27
- TRELEGY ELLIPTA (Drug) $11.00
- Xofluza (Drug) $10.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Crestwood
Alyssa Dykgraaf, Dmd, DMD
Student in an Organized Health Care Education/Training Program — Payments: $148.41
Jessica Socha
Student in an Organized Health Care Education/Training Program
Courtney Schmitt
Student in an Organized Health Care Education/Training Program
Jocelyn Lara
Student in an Organized Health Care Education/Training Program
Jennifer Stamos
Student in an Organized Health Care Education/Training Program
Dinah Tadros
Student in an Organized Health Care Education/Training Program